Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy. [electronic resource]
Producer: 20210211Description: 894-907 p. digitalISSN:- 2162-4011
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.